| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1596be8991f8d463e4f481688a269ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d0f303bb77f75e15b73938eb53e20ec1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dee3727dba91e4e7aa3b26ce9efbcc21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b5d856a9d1d51c89dca955a647a07ed |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-807
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-86 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-807
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-68 |
| filingDate |
2011-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b6305a208584b8365d4097915de4852
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5611465cd692eb924fc092a860cab0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a8a158c11d8727213cabe25a32f702a |
| publicationDate |
2015-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9085538-B2 |
| titleOfInvention |
Process for the preparation of key intermediates for the synthesis of statins or pharmaceutically acceptable salts thereof |
| abstract |
The invention relates to commercially viable process for the synthesis of key intermediates for the preparation of statins, in particular Rosuvastatin and Pitavastatin or respective pharmaceutically acceptable salts thereof. A new simple and short synthetic route for key intermediates is presented which benefits from the use of cheap and readily available starting materials, by which the conventionally most frequently used DIBAL-H as reducing agent can be avoided. |
| priorityDate |
2010-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |